Anti-LGMD2I antibodies enable researchers to detect and measure the LGMD2I antigen in biological samples. This target is a reported synonym of the FKRP gene, which encodes fukutin related protein. This protein is known to catalyze the transfer of a ribitol 5-phosphate from CDP-L-ribitol to the ribitol 5-phosphate previously attached by FKTN/fukutin to the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1). The human version of LGMD2I has a canonical amino acid length of 495 residues and a protein mass of 54.6 kilodaltons. It is reported to be localized in the cell membrane, ER, Golgi, cytoplasm, and is secreted of cells and notably expressed in the placenta, kidney, duodenum, colon, and cerebral cortex. LGMD2I is a member of the LicD transferase protein family. Indicated applications for LGMD2I antibodies listed below include ELISA and Western Blot.